Takeda Pharmaceuticals Reports - Industry Research

Reports Featuring Takeda Pharmaceuticals

Carbonated Beverages Market Major Players

Insomnia Treatment Market

The Insomnia Treatment Market size is estimated at USD 3.58 billion in 2024, and is expected to reach USD 4.60 billion by 2029, growing at a CAGR of 5.16% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Japan Pharmaceutical Market

The Japan Pharmaceutical Market size is estimated at USD 88 billion in 2024, and is expected to reach USD 91.94 billion by 2029, growing at a CAGR of 0.88% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Global Orphan Drugs Market

The Global Orphan Drugs Market size is estimated at USD 217.35 billion in 2024, and is expected to reach USD 294.17 billion by 2029, growing at a CAGR of 6.24% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Proton Pump Inhibitors Market

The proton pump inhibitors market is poised to grow at a CAGR of 4.5% during the forecast period of the study.

Carbonated Beverages Market Major Players

North America Biguanide Market

The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Inflammatory Bowel Disease (IBD) Therapeutics Market

The Inflammatory Bowel Disease Therapeutics Market size in terms of Equal-5.15 is expected to grow from USD 24.46 billion in 2024 to USD 31.43 billion by 2029, at a CAGR of 5.15% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Japan Diabetes Drugs Market

The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

North America Alpha-Glucosidase Inhibitors Market

The North America Alpha-Glucosidase Inhibitors Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.32 billion by 2029, growing at a CAGR of 2.5% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Smoking Cessation Aids Market

The smoking cessation aid market is expected to register a CAGR of 12.5% over the forecast period.

Carbonated Beverages Market Major Players

Gastrointestinal Therapeutics Market

The Gastrointestinal Therapeutics Market size is estimated at USD 0.08 billion in 2024, and is expected to reach USD 0.1 billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Global Polycystic Ovarian Syndrome Treatment Market

The polycystic ovarian syndrome (PCOS) treatment market is expected to register a growth rate of 5.2% over the forecast period., 2022-2027.

Carbonated Beverages Market Major Players

Gastroesophageal Reflux Disease Market

The gastroesophageal reflux disease market is poised to grow at a CAGR of 4.3% over the forecast period.

Carbonated Beverages Market Major Players

Global Constipation Treatment Market

The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.

Carbonated Beverages Market Major Players

Red Biotechnology Market

The red biotechnology market is expected to register a CAGR of 6.1% over the forecast period.

Carbonated Beverages Market Major Players

Plasma Protein Therapeutics Market

The plasma protein therapeutics market has been projected to register a CAGR of 5.3% over the forecast period.

Carbonated Beverages Market Major Players

Global Guillain-Barre Syndrome Market

The Guillain-Barre Syndrome Market studied is anticipated to grow at a CAGR of 5.2% during the forecast period, 2022-2027.

Carbonated Beverages Market Major Players

Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Europe Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 1.79 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 2.73% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Global Gout Therapeutics Market

The Gout Therapeutics market is anticipated to grow with a CAGR of 15.5%, over the forecast period (2022 - 2027).

Carbonated Beverages Market Major Players

Global Rare Hemophilia Factors Market

The rare hemophilia factors market is expected to record a CAGR of 4.3% over the forecast period (2022-2027).

Carbonated Beverages Market Major Players

Global Intravenous Immunoglobulin Market

The intravenous immunoglobulin market is expected to register a CAGR of 7.13% over the forecast period, 2022-2027.

Carbonated Beverages Market Major Players

Short Bowel Syndrome Market

The short bowel syndrome (SBS) market is anticipated to grow with a CAGR of 12.1%, during the forecast period.

Carbonated Beverages Market Major Players

Chronic Myelogenous Leukemia Treatment Market

The chronic myelogenous leukemia (CML) treatment market is expected to register a CAGR of 5.3% over the forecast period.

Carbonated Beverages Market Major Players

Global Narcolepsy Therapeutics Market

The narcolepsy therapeutics market is anticipated to witness a CAGR of 9.9% during the forecast period (2022-2027).

Carbonated Beverages Market Major Players

Myelodysplastic Syndrome (MDS) Treatment Market

The myelodysplastic syndrome (MDS) treatment market is projected to register a CAGR of 6.5% during the forecast period, 2022-2027.

Carbonated Beverages Market Major Players

Global Myeloproliferative Disorders (MPD) Treatment Market

The myeloproliferative disorders (MPD) treatment market is expected to register a CAGR of 4.9% over the forecast period.

Carbonated Beverages Market Major Players

Global Hereditary Angioedema Therapeutics Market

The hereditary angioedema therapeutics market is expected to register a CAGR of 8.5% during the forecast period.

Carbonated Beverages Market Major Players

Lysosomal Storage Disease Treatment Market

The lysosomal storage disease treatment market is expected to register a CAGR of 8.2% during the forecast period.

Carbonated Beverages Market Major Players

Enzyme Replacement Therapy Market

The enzyme replacement therapy market is expected to register a CAGR of 7.7% during the forecast period.

Carbonated Beverages Market Major Players

Sleep Disorders Treatment Market

The sleep disorders treatment market is anticipated to witness a CAGR of nearly 7.1% during the forecast period.

Carbonated Beverages Market Major Players

Preterm Birth Prevention and Management Market

The preterm birth prevention and management market is expected to register a CAGR of 5.4% over the forecast period.

Carbonated Beverages Market Major Players

Global Addison's Disease Treatment Market

Addison's Disease Treatment market is projected to register a CAGR of 4.1% during the forecast period (2022 - 2027).

Carbonated Beverages Market Major Players

Central Nervous System (CNS) Stimulant Drugs Market

The central nervous system (CNS) stimulant drugs market is expected to register a CAGR of 5.5% over the forecast period.

Carbonated Beverages Market Major Players

Alpha-glucosidase Inhibitors Market

The Alpha-glucosidase Inhibitors Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 5.30 billion by 2029, growing at a CAGR of 2.17% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Biguanides Market

The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Von Willebrand Disease Treatment Market

The Von Willebrand disease (VWD) treatment market is expected to register a CAGR of 6.5% during the forecast period.

Carbonated Beverages Market Major Players

Antithrombin Market

The antithrombin market is expected to register a CAGR of 4.3% over the forecast period.

Carbonated Beverages Market Major Players

Global Primary Immunodeficiency Therapeutics Market

The Primary Immunodeficiency Therapeutics Market is expected to register a CAGR of 6.1% during the forecast period.

Carbonated Beverages Market Major Players

Subcutaneous Immunoglobulin Market

The subcutaneous immunoglobulin market studied was projected to grow with a CAGR of nearly 13.3% over the forecast period.

Carbonated Beverages Market Major Players

Blood Disorder Therapeutics Market

The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.

Carbonated Beverages Market Major Players

Multiple Myeloma Market

The multiple myeloma market is expected to witness a CAGR of 6% over the forecast period.

Carbonated Beverages Market Major Players

Global Pericarditis Drugs Market

The pericarditis drugs market is expected to register a CAGR of 5.2% over the forecast period (2022-2027).

Carbonated Beverages Market Major Players

Japan Container Glass Market

The Japan Container Glass Market is expected to register a CAGR of 3.2% during the forecast period (2020 - 2027).

Carbonated Beverages Market Major Players

MEA Uterine Cancer Therapeutics & Diagnostics Market

The Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market is expected to grow with a CAGR of 5.7% during the forecasted period.

Carbonated Beverages Market Major Players

Uterine Cancer Therapeutics & Diagnostics Market

The Uterine Cancer Therapeutics & Diagnostics Market is expected to witness a growth of 6% CAGR owing to the growing awareness of uterine cancer and increasing healthcare expenditure.

Carbonated Beverages Market Major Players

APAC Uterine Cancer Therapeutics & Diagnostics Market

The Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 2.5% during the forecast period.

Carbonated Beverages Market Major Players

Plasma Protease C1-inhibitor Market

The Plasma Protease C1-inhibitor Treatment Market is expected to experience a significant growth over the forecast period due to the growing incidence of hereditary angioedema (HAE).

Carbonated Beverages Market Major Players

Hunter Syndrome Treatment Market

The hunter syndrome treatment market is expected to be valued at USD 1,265 million, at a CAGR of nearly 5.2%, during the forecast period.

Carbonated Beverages Market Major Players

Ubiquitin Proteasome Market

The Ubiquitin Proteasome market studied is anticipated to grow with a CAGR of nearly 3.9%, during the forecast period.

Carbonated Beverages Market Major Players

Fabry Disease Treatment Market

The Fabry disease treatment market is expected to register a CAGR of 6.8% over the forecast period.

Carbonated Beverages Market Major Players

APAC Biguanide Market

The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Europe Alpha-Glucosidase Inhibitors Market

The Europe Alpha-Glucosidase Inhibitors Market size is expected to reach USD 1 billion over the forecast year, growing at a CAGR of 2.20% during the forecast period.

Carbonated Beverages Market Major Players

Latin America Alpha-Glucosidase Inhibitors Market

The Latin America Alpha-Glucosidase Inhibitors Market size is expected to grow from USD 72.47 million in current year to USD 85.24 million by forecast year, at a CAGR of 3.30% during the forecast period.

Carbonated Beverages Market Major Players

Middle East and Africa Alpha-Glucosidase Inhibitors Market

The Middle-East and Africa Alpha-Glucosidase Inhibitors Market size is estimated at USD 57.37 million in current year, and is expected to reach USD 68.46 million by forecast year, growing at a CAGR of 3.60% during the forecast period.

Carbonated Beverages Market Major Players

Asia-Pacific Alpha-Glucosidase Inhibitors Market

The Asia-Pacific Alpha-Glucosidase Inhibitors Market size is estimated at USD 4.14 billion in current year, and is expected to reach USD 4.64 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.

Other Reports Covering Takeda Pharmaceuticals

Pharmaceuticals